Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if a type of anti-HIV therapy called HAART is effective
in lowering levels of HIV and boosting the immune system in HIV-infected patients with
tuberculosis (TB).
HIV-infected patients with TB have higher levels of HIV and lower CD4 cell counts (cells in
the body that fight infection) than HIV-infected patients without TB. HAART has been
effective in reducing HIV levels and increasing CD4 cells in patients without TB. However,
its effects in HIV-infected patients with TB are unknown.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)